Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease non-alcoholic fatty liver disease
Comorbidity C0042373|vascular disease
Sentences 21
PubMedID- 20879883 Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease.
PubMedID- 21749681 Recently, an increased risk of cardiovascular disease in patients with nafld has been also suggested [17], based on the strong association between nafld and ms [18].
PubMedID- 24713805 Cardiovascular disease in patients with non-alcoholic fatty liver disease.
PubMedID- 22081919 Cardiovascular disease associated with mets or nafld should be managed aggressively.
PubMedID- 26049073 Increasing evidence now suggests that nafld is also associated with higher cardiovascular disease (cvd) morbidity and mortality independent of conventional cardiometabolic risk factors (such as obesity, insulin resistance, and diabetes mellitus).
PubMedID- 25634387 Our study is designed to investigate the association of nafld with cardiovascular disease.
PubMedID- 20460913 The role of non-alcoholic fatty liver disease in cardiovascular disease.
PubMedID- 20658466 The potential role of nafld in cardiovascular disease (cvd) has also attracted interest.
PubMedID- 24824123 Objective: to study the relationship between non-alcoholic steatohepatitis (nash) and atherosclerosis in young and middle-aged patients, and to provide clinical evidence that will aid in prevention and prediction of development of atherosclerosis or cardiovascular diseases in patients with non-alcoholic fatty liver disease (nafld).
PubMedID- 25644347 Background: nonalcoholic fatty liver disease is positively associated with obesity and cardiovascular disease risk.
PubMedID- 23534297 [cardiovascular disease risk factors in patients with non-alcoholic fatty liver disease].
PubMedID- 22189171 Aims: non-alcoholic fatty liver disease (nafld) is associated with cardiovascular disease.
PubMedID- 25126490 non-alcoholic fatty liver disease (nafld) is associated with increased cardiovascular disease (cvd) risk in children.
PubMedID- 24075754 A systematic review: burden and severity of subclinical cardiovascular disease among those with nonalcoholic fatty liver; should we care.
PubMedID- 24638096 Many patients suffering from metabolic syndrome involving obesity, dyslipidemia, hypertension, insulin-resistant type-2 diabetes mellitus and atherosclerotic cardiovascular disease are associated with nafld [1], [2], [3], [4], [5].
PubMedID- 23895155 Post-menopause, there is an increase in body weight, visceral adiposity, and risk of developing non-alcoholic fatty liver disease (nafld), which leads to various cardiovascular diseases (cvds).
PubMedID- 25563143 The aim of this review is to summarize the available data linking nafld with cardiovascular disease (cvd).
PubMedID- 24118857 Background & aims: non-alcoholic fatty liver disease (nafld) is associated with increased cardiovascular disease (cvd) risk.
PubMedID- 26477269 In this updated clinical review, we discuss the rapidly expanding body of clinical and epidemiological evidence that supports a strong association of nafld with cardiovascular diseases (cvds) and other functional and structural myocardial abnormalities.
PubMedID- 22676459 Recently adiponectin has been considered as a possible link between liver dysfunction and atherosclerotic vascular disease in patients with nafld [35].
PubMedID- 26528002 The mechanisms linking nafld with cardiovascular disease are not fully understood yet, but attention was focused primarily on insulin resistance.

Page: 1